Medium and small scale pharma units in India need to update themselves to survive in changing regulatory and intellectual property environment. The government through the new IPR policy and amendment to the Rules (2016) is sending out clear signals that patents will be enforced in India to protect the patentee’s rights, according to Dr. Gopakumar G Nair, CEO, Gopakumar Nair Associates.
